Mark Wilson, chief executive officer, Cochrane, said, “The Cochrane Library is central to Cochrane’s mission of producing and making available to the world high-quality, relevant, accessible systematic reviews and other evidence synthesis. Traffic to the Library has greatly increased over the past seven years as we have made it accessible in 12 languages and we have built a publishing platform that will enable us to deliver new journals, new databases and new features that will help us meet that mission as never before. We are confident we have a strong strategic partner with whom to work on the longer-term publishing challenges and opportunities.”

Cochrane’s current publishing contract with Wiley ends on 31 December 2020. Following a competitive tender process beginning in May 2019 that attracted bids from numerous publishers, Wiley was selected due to its commitment to product development and innovation; a strategic vision meeting the needs of users of Cochrane’s evidence; and, support for the organisation’s multi-lingual strategy, thus increasing the accessibility of its evidence globally.

The agreement also secures a strong financial framework to support Cochrane’s organisational ambitions in the next decade, including its Open Access aspirations. Currently, more than 3.6-billion people have free one-click access to the Cochrane Library, with nearly 70% of all 8,300 Cochrane Reviews and all 2,400 Review protocols available to everyone across the world.

“Cochrane is the world-leading provider of medical evidence to support clinical effectiveness,” said Jay Flynn, senior vice-president and chief product officer, research at Wiley. “We are confident this new agreement provides a strong framework within which to sustain Cochrane’s success and advance its future growth.”

Karla Soares-Weiser, Cochrane’s editor in chief, said: “The Cochrane Library is pivotal in delivering Cochrane’s mission of producing high-quality, relevant, up-to-date systematic reviews and other synthesized research evidence to inform health decision making. Future publication and dissemination of our content are keys to meeting Cochrane’s strategic goals and the long-term financial health of our global organisation.”